Human antibodies and proteins

Details for Australian Patent Application No. 2012209017 (hide)

Owner Antitope Limited

Inventors Jones, Timothy David; Baker, Matthew Paul

Agent Pegasus IP

Pub. Number AU-A-2012209017

Parent 2006210724

Filing date 31 July 2012

Wipo publication date 16 August 2012

International Classifications

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 14/18 Peptides having more than 20 amino acids

C07K 14/415 Peptides having more than 20 amino acids - from plants

C07K 14/815 Peptides having more than 20 amino acids

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/42 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 Hybrid peptides

Event Publications

16 August 2012 Application Open to Public Inspection

  Published as AU-A-2012209017

16 August 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012209018-Methods for isolating crystalline Form I of 5-azacytidine

2012209016-Inclination detection systems and methods